Technical Analysis for CPH - Cipher Pharmaceuticals Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Bearish Engulfing | Bearish | -3.99% | |
Slingshot Bullish | Bullish Swing Setup | -3.99% | |
NR7 | Range Contraction | -3.99% | |
Upper Bollinger Band Walk | Strength | -3.99% | |
Wide Bands | Range Expansion | -3.99% | |
Overbought Stochastic | Strength | -3.99% | |
Shooting Star Candlestick | Bearish | -6.32% |
Alert | Time |
---|---|
Fell Below 10 DMA | about 18 hours ago |
Down 1 ATR | about 21 hours ago |
10 DMA Support | about 21 hours ago |
Down 5% | about 21 hours ago |
2x Volume Pace | about 21 hours ago |
Get a Trading Sidekick!
- Earnings date: 2024-05-09
Cipher Pharmaceuticals Inc. Description
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical dermatology company. The Company has a portfolio of commercial and late-stage products. It operates in the specialty pharmaceuticals segment. It acquires products and compounds for treatment of various medical needs. Its commercial product portfolio includes ABSORICA; SITAVIG; NUVAIL; BIONECT; CLN8; INOVA; PRO:12 MOUSSE; AL12; LOTION UMECTA; ACLARO; EPURIS; VANIQA; ACTIKERALL; BETEFLAM; LIPOFEN; CONZIP, and DURELA. Its products treat indications, such as severe nodular acne, recurrent herpes labialis, nail dystrophy, dermal ulcers, mild/moderate onychomycosis, acne, dry skin, keratosis, hyperpigmentation, hyperkeratotic actinic keratosis and high cholesterol. Its pipeline of late-stage products includes DERMADEXIN, BETEFLAM PATCH, SITAVIG, PRURIDEXIN, OZENOXACIN, CF101 for plaque psoriasis, CF101 for rheumatoid arthritis, ASF-1096 and NANOLIPOLEE-007. It operates in Canada and the United States.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharma Pipe Pharmaceutical Pipeline RTT Skin Pharmaceuticals IPO Organ Systems Arthritis Ulcer Dermatology Nail Psoriasis Acne Actinic Keratosis Herpes Labialis Keratosis Onychomycosis Rheumatoid Arthritis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 9.98 |
52 Week Low | 3.11 |
Average Volume | 43,968 |
200-Day Moving Average | 5.229 |
50-Day Moving Average | 7.119 |
20-Day Moving Average | 8.005 |
10-Day Moving Average | 8.861 |
Average True Range | 0.471 |
RSI (14) | 65.40 |
ADX | 37.57 |
+DI | 35.772 |
-DI | 17.066 |
Chandelier Exit (Long, 3 ATRs) | 8.569 |
Chandelier Exit (Short, 3 ATRs) | 8.082 |
Upper Bollinger Bands | 9.846 |
Lower Bollinger Band | 6.164 |
Percent B (%b) | 0.74 |
BandWidth | 45.994 |
MACD Line | 0.626 |
MACD Signal Line | 0.517 |
MACD Histogram | 0.1086 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.905 | ||||
Resistance 3 (R3) | 9.970 | 9.700 | 9.738 | ||
Resistance 2 (R2) | 9.700 | 9.444 | 9.668 | 9.682 | |
Resistance 1 (R1) | 9.300 | 9.286 | 9.165 | 9.235 | 9.626 |
Pivot Point | 9.030 | 9.030 | 8.963 | 8.998 | 9.030 |
Support 1 (S1) | 8.630 | 8.774 | 8.495 | 8.565 | 8.174 |
Support 2 (S2) | 8.360 | 8.616 | 8.328 | 8.118 | |
Support 3 (S3) | 7.960 | 8.360 | 8.063 | ||
Support 4 (S4) | 7.895 |